Development of a neutralization assay for influenza virus using an endpoint assessment based on quantitative

Belete Teferedegne1, Andrew M Lewis, Keith Peden

  • 1Laboratory of DNA Viruses, Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, USA.

Plos One
|February 26, 2013
PubMed

Related Concept Videos